Global Hyperhidrosis Treatment Market Size, Share, Forecast Report, 2020-2027

Hyperhidrosis Treatment Market is expected to hold a value of USD 1,925.9 Million by 2025 at a CAGR of 6.07%.
Despite being one of the most commonly occurring conditions, the hyperhidrosis treatment market continues to grow at a moderate rate. Antiperspirants and topical products are the first line of treatment in the hyperhidrosis treatment market. However, there is no permanent cure to hyperhidrosis yet. However, there has been high activity in terms of technological developments and product developments in the past few years. Also, with growing awareness about the treatment options and patient’s inclination towards novel approaches has been an encouraging factor for the companies to invest in this market.
Segmentation

By Type

Primary Hyperhidrosis: It is a disorder with symptoms such as abnormal sweating. The sweating is not necessarily related to exercise or heat. The most commonly affected areas by hyperhidrosis are armpits, palms of the hands, soles of the feet, under the breasts, and groin area. The primary hyperhidrosis segment captures the larger market share.
Secondary Generalized Hyperhidrosis: In secondary generalized hyperhidrosis the sweating is caused due to another medical condition such as hypertension and cardiovascular diseases, among others. It does not affect any particular body part, and the and perspiration occurs all over the affected person’s body.
By Treatment

Botulinum Toxin Injections: Botulinum toxin (Botox) is a neurotoxin, which is a relatively new treatment approach for the treatment of hyperhidrosis. Botox is the Food and Drug Administration (FDA)-approved treatment for axillary hyperhidrosis. Generally, doctors recommend Botox injections only when the patient continues to experience the hyperhidrosis episodes despite the use of prescription antiperspirants, and the condition does not improve.
Topical Treatment: Topical treatment generally includes over-the-counter (OTC) antiperspirants. These are considered the first line of treatment for hyperhidrosis. If the patient is not relieved by using the OTC antiperspirants, prescription antiperspirants are used.
Surgical Treatment: The surgical treatment includes sweat gland removal surgery and endoscopic thoracic sympathectomy (ETS). Sweat gland removal surgery is done when there is a need for permanent sweat gland removal in case of severe armpit sweating. ETS is a minimally invasive surgical procedure commonly used for the hyperhidrosis of hands. Besides that, lasers treatments are also a common surgical procedure.
Oral Medication: Although there are no specific drugs targeted for the treatment of hyperhidrosis, oral medicines such as anticholinergics have found some success and are commonly used. Some of the examples of anticholinergics are glycopyrrolate, oxybutynin, benztropine, propantheline, and others.
Microwave Therapy: Also known as microwave thermolysis, works on the principle of directing energy to the sweat glands of the armpit and destroying them.
Others: The other segment includes iontophoresis.
By End-User

Dermatology Clinics: Dermatology clinics account for the largest share of this segment in the hyperhidrosis treatment market. Dermatology clinics offer a number of treatments ranging from Botox treatment to surgical and laser therapy.
Ambulatory Surgery Centers: Ambulatory surgical centers offer outpatient services related to hyperhidrosis treatment. Ambulatory surgery centers are the fastest-growing segment in the hyperhidrosis market.
Payers/Patients: This segment includes the individual patients who tend to buy the medication, topical creams, and antiperspirants for the treatment of hyperhidrosis.
Others: This segment includes research organizations and academic institutions.

Key Players

• Allergan PLC (Ireland)
• Brickell Biotech Inc. (US)
• Cynosure (US)
• Dermadry Laboratories lnc. (Canada)
• Dermira Inc. (US)
• GlaxoSmithKline PLC (UK)
• Miramar Labs, Inc. (US)
• Sesderma (Spain)
• Ulthera Inc. (US)